199 related articles for article (PubMed ID: 31114334)
1. Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.
Wu X; Yan T; Hao L; Zhu Y
Cancer Manag Res; 2019; 11():2803-2815. PubMed ID: 31114334
[No Abstract] [Full Text] [Related]
2. Wnt5a/ROR1 activates DAAM1 and promotes the migration in osteosarcoma cells.
Dai B; Shen Y; Yan T; Zhang A
Oncol Rep; 2020 Feb; 43(2):601-608. PubMed ID: 31894282
[TBL] [Abstract][Full Text] [Related]
3. Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion.
Liu G; Yan T; Li X; Sun J; Zhang B; Wang H; Zhu Y
Oncol Rep; 2018 Feb; 39(2):465-472. PubMed ID: 29207169
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
5. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
Endo M; Doi R; Nishita M; Minami Y
J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
[TBL] [Abstract][Full Text] [Related]
6. Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration.
Zhu Y; Tian Y; Du J; Hu Z; Yang L; Liu J; Gu L
PLoS One; 2012; 7(5):e37823. PubMed ID: 22655072
[TBL] [Abstract][Full Text] [Related]
7. Role of the Ror family receptors in Wnt5a signaling.
Kamizaki K; Minami Y; Nishita M
In Vitro Cell Dev Biol Anim; 2024 Apr; ():. PubMed ID: 38587578
[TBL] [Abstract][Full Text] [Related]
8. ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a.
Dai B; Yan T; Zhang A
Cancer Cell Int; 2017; 17():112. PubMed ID: 29213214
[TBL] [Abstract][Full Text] [Related]
9. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
Qi X; Okinaka Y; Nishita M; Minami Y
Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
[TBL] [Abstract][Full Text] [Related]
10. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
Endo M; Nishita M; Fujii M; Minami Y
Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.
Hasan MK; Yu J; Chen L; Cui B; Widhopf Ii GF; Rassenti L; Shen Z; Briggs SP; Kipps TJ
Leukemia; 2017 Dec; 31(12):2615-2622. PubMed ID: 28465529
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
[TBL] [Abstract][Full Text] [Related]
14. Integrin αvβ3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells.
Yan T; Zhang A; Shi F; Chang F; Mei J; Liu Y; Zhu Y
J Biol Chem; 2018 Jun; 293(26):10172-10185. PubMed ID: 29752407
[TBL] [Abstract][Full Text] [Related]
15. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.
Yu J; Chen L; Chen Y; Hasan MK; Ghia EM; Zhang L; Wu R; Rassenti LZ; Widhopf GF; Shen Z; Briggs SP; Kipps TJ
Leukemia; 2017 Dec; 31(12):2608-2614. PubMed ID: 28465528
[TBL] [Abstract][Full Text] [Related]
17. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
18. The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease.
Endo M; Kamizaki K; Minami Y
Front Cell Dev Biol; 2022; 10():891763. PubMed ID: 35493090
[TBL] [Abstract][Full Text] [Related]
19. Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
Meagher M; Krause H; Elliott A; Farrell A; Antonarakis ES; Bastos B; Heath EI; Jamieson C; Stewart TF; Bagrodia A; Nabhan C; Oberley M; McKay RR; Salmasi A
Cancer Med; 2024 Apr; 13(7):e7148. PubMed ID: 38558536
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
